UA5576A1 - Спосіб отримання похідних 3,5-діаміно-1,2,4-триазіну або їх кислотно-адітивних солей - Google Patents

Спосіб отримання похідних 3,5-діаміно-1,2,4-триазіну або їх кислотно-адітивних солей

Info

Publication number
UA5576A1
UA5576A1 UA2932704A UA2932704A UA5576A1 UA 5576 A1 UA5576 A1 UA 5576A1 UA 2932704 A UA2932704 A UA 2932704A UA 2932704 A UA2932704 A UA 2932704A UA 5576 A1 UA5576 A1 UA 5576A1
Authority
UA
Ukraine
Prior art keywords
acid
diamino
triazine
derivatives
preparation
Prior art date
Application number
UA2932704A
Other languages
English (en)
Russian (ru)
Inventor
Елан Сойер Девід
Джордж Бакстер Мартін
Реджинальд-Елфік Альберт
Айнслі Міллер Алістер
Original Assignee
Дзе Велкам Фаундейшн, Лимітед
Дзе Велкам Фаундейшн, Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10505597&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA5576(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Дзе Велкам Фаундейшн, Лимітед, Дзе Велкам Фаундейшн, Лимитед filed Critical Дзе Велкам Фаундейшн, Лимітед
Publication of UA5576A1 publication Critical patent/UA5576A1/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/15Preparation of carboxylic acids or their salts, halides or anhydrides by reaction of organic compounds with carbon dioxide, e.g. Kolbe-Schmitt synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/363Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Предметом винаходу є спосіб одержання похідних 3,5-діаміно-1,2,4-триазину або їх кислотно-адитивних солей. Сполуки нагріваються при 50-100°С в інертному розчиннику, у якому розчинні реагенти, з наступним виділенням цільового продукту у виді основи або кислотно-адитивної солі, або ацилюванням і виділенням цільового продукту у виді основи або кислотно-адитивної солі.
UA2932704A 1979-06-01 1980-06-02 Спосіб отримання похідних 3,5-діаміно-1,2,4-триазіну або їх кислотно-адітивних солей UA5576A1 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7919257 1979-06-01

Publications (1)

Publication Number Publication Date
UA5576A1 true UA5576A1 (uk) 1994-12-28

Family

ID=10505597

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2932704A UA5576A1 (uk) 1979-06-01 1980-06-02 Спосіб отримання похідних 3,5-діаміно-1,2,4-триазіну або їх кислотно-адітивних солей

Country Status (30)

Country Link
US (2) US4486354A (uk)
EP (2) EP0059987B1 (uk)
JP (2) JPS5625169A (uk)
AR (1) AR227521A1 (uk)
AT (1) AT370097B (uk)
AU (2) AU530999B2 (uk)
BG (1) BG60427B2 (uk)
CA (1) CA1112643A (uk)
CS (1) CS234018B2 (uk)
CZ (1) CZ384891A3 (uk)
DD (1) DD151309A5 (uk)
DK (1) DK153787C (uk)
ES (1) ES491998A0 (uk)
FI (1) FI67844C (uk)
GE (1) GEP19960470B (uk)
GR (1) GR68380B (uk)
HU (1) HU182086B (uk)
IE (1) IE49823B1 (uk)
IL (1) IL60201A (uk)
IT (1) IT1147087B (uk)
MX (1) MX9202962A (uk)
MY (1) MY8500062A (uk)
NL (1) NL950007I2 (uk)
NZ (1) NZ193890A (uk)
PL (1) PL124029B1 (uk)
SU (1) SU1055331A3 (uk)
UA (1) UA5576A1 (uk)
YU (1) YU145680A (uk)
ZA (1) ZA803250B (uk)
ZW (1) ZW12980A1 (uk)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0086502B1 (en) * 1979-08-16 1987-03-25 The Wellcome Foundation Limited Substituted aromatic triazines
GB8328757D0 (en) * 1983-10-27 1983-11-30 Wellcome Found Chemical compounds
DE3600891A1 (de) * 1986-01-15 1987-07-16 Bayer Ag 1,8-verbrueckte 4-chinolon-3-carbonsaeuren und diese enthaltende arzneimittel
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
US4972496A (en) * 1986-07-25 1990-11-20 Grid Systems Corporation Handwritten keyboardless entry computer system
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.
US5136080A (en) * 1989-12-04 1992-08-04 Burroughs Wellcome Co. Nitrile compounds
GB9012311D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
GB9012312D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
ES2080641B1 (es) * 1991-01-30 1996-11-01 Wellcome Found Procedimiento para preparar comprimidos dispersables en agua.
GB9124807D0 (en) * 1991-11-22 1992-01-15 Wellcome Found Pharmaceutical formulations
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
GB9203483D0 (en) * 1992-02-19 1992-04-08 Wellcome Found Anti-inflammatory compounds
AU688729B2 (en) * 1992-06-12 1998-03-19 Wellcome Foundation Limited, The Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine isethionate for the treatment and prevention of dependence, tolerance and sensitization of drugs
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
FR2699077B1 (fr) * 1992-12-16 1995-01-13 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes.
US6133299A (en) * 1993-02-25 2000-10-17 Warner-Lambert Company Methods for treating neurodegenerative diseases and disorders using N-(2,6-disubstituted aromatic)-N'-pyridinyl ureas and other anticonvulsant compounds
US5866597A (en) * 1993-03-19 1999-02-02 Glaxo Wellcome Inc. Use of triazine compounds for the treatment of memory and learning disorders
GB9305692D0 (en) * 1993-03-19 1993-05-05 Wellcome Found Therapeutic triazine compounds and use
GB9305693D0 (en) * 1993-03-19 1993-05-05 Wellcome Found Therapeutic triazine compounds and use
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
GB9317146D0 (en) * 1993-08-18 1993-10-06 Wellcome Found Therapeutic combinations
GB9424766D0 (en) * 1994-12-07 1995-02-08 Wellcome Found Pharmaceutical composition
HU224688B1 (hu) * 1994-12-30 2005-12-28 The Wellcome Foundation Limited Eljárás 3,5-diamino-6-(2,3-diklór-fenil)-1,2,4-triazin (lamotrigin) előállítására
GB9426448D0 (en) * 1994-12-30 1995-03-01 Wellcome Found Process
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation
GB9518027D0 (en) * 1995-09-05 1995-11-08 Wellcome Found Pharmacologically active compound
FR2741879A1 (fr) * 1995-12-05 1997-06-06 Esteve Labor Dr Derives de fluorophenyl-triazines et pyrimidines, leur preparation et leur application en tant que medicament
US6202491B1 (en) 1997-07-22 2001-03-20 Skf Condition Monitoring, Inc. Digital vibration coupling stud
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds
US6124500A (en) * 1998-03-09 2000-09-26 Rohm And Haas Company Process for synthesizing benzoic acids
GB9812413D0 (en) 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
CA2334937C (en) * 1998-12-14 2004-09-21 Torrent Pharmaceuticals Ltd. An improved process for the preparation of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
US20020055177A1 (en) * 1999-03-10 2002-05-09 Glaxo Wellcome Inc. Compound and its use
GB9907965D0 (en) 1999-04-09 1999-06-02 Glaxo Group Ltd Medical use
AU4334900A (en) * 1999-04-09 2000-11-14 Euro-Celtique S.A. Sodium channel blocker compositions and the use thereof
US6639072B1 (en) 2000-01-03 2003-10-28 Rpg Life Sciences Limited Process for the preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, commonly known as lamotrigine
IL134730A (en) * 2000-02-25 2003-10-31 Chemagis Ltd Process for preparing substituted benzoyl cyanide amidinohydrazones
JP2004514699A (ja) 2000-11-30 2004-05-20 ファイザー・プロダクツ・インク Gabaアゴニストおよびソルビトールデヒドロゲナーゼ阻害剤の組合せ
CN1477976A (zh) 2000-11-30 2004-02-25 �Ʒ� Gaba激动剂与醛糖还原酶抑制剂的组合
WO2002068398A1 (en) * 2001-02-27 2002-09-06 Teva Pharmaceutical Industries Ltd. New crystal forms of lamotrigine and processes for their preparations
ES2253579T3 (es) * 2001-09-03 2006-06-01 Newron Pharmaceuticals S.P.A. Composicion farmaceutica que comprende gabapentina o un analogo suyo y una alfa-aminoamida y su uso analgesico.
CA2366521C (en) 2001-12-24 2007-03-06 Brantford Chemicals Inc. A new and efficient process for the preparation of lamotrigine and related 3,5-diamino-6-substituted-1,2,4-triazines
EP2316469A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
AU2003234240A1 (en) * 2002-04-23 2003-11-10 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing lamotrigine particles of defined morphology
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
HU225667B1 (en) 2002-09-20 2007-05-29 Richter Gedeon Nyrt Method for producing high-purity 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
ES2209639B1 (es) 2002-10-31 2005-08-01 Vita Cientifica, S.L. Procedimiento para la obtencion de un compuesto farmaceuticamente activo y obtencion de su intermedio.
AU2003217437A1 (en) * 2003-03-17 2004-10-11 Hetero Drugs Limited Novel crystalline forms of lamotrigine
AU2003230193A1 (en) 2003-03-27 2004-10-18 Hetero Drugs Limited Novel crystalline forms of candesartan cilexetil
AU2004237951A1 (en) * 2003-05-16 2004-11-25 Pfizer Products Inc. Therapeutic combinations of atypical antipsychotics with GABA modulators, anticonvulsants or benzodiazapines
WO2004103340A1 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited Water dispersible tablets of lamotrigine
GB2395483A (en) * 2003-07-03 2004-05-26 Jubilant Organosys Ltd Crystalline lamotrigine and its monohydrate
JP5646126B2 (ja) 2003-12-11 2014-12-24 サノビオン ファーマシューティカルズ インクSunovion Pharmaceuticals Inc. 鎮静剤と神経伝達物質調節剤の併用、および睡眠の質の向上方法および鬱の治療方法
CA2553291A1 (en) * 2004-01-29 2005-09-09 Pfizer Products Inc. Combination of .gamma.-aminobutyric acid modulators and 5-ht1b receptor antagonists
CA2567249A1 (en) * 2004-04-19 2006-10-05 Jds Pharmaceuticals, Llc Lithium combinations, and uses related thereto
US20080096965A1 (en) * 2004-09-10 2008-04-24 Newron Pharmaceuticals S.P.A. (Halobenzyloxy) Benzylamino-Propanamides as Sodium and/or Calcium Channel Selective Modulators
US7825151B2 (en) * 2005-09-23 2010-11-02 Janssen Pharmaceutica Nv Hexahydro-cyclooctyl pyrazole cannabinoid modulators
WO2007044215A1 (en) * 2005-09-23 2007-04-19 Janssen Pharmaceutica, N.V. Hexahydro cyclooctyl pyrazole cannabinoid modulators
US8378117B2 (en) * 2005-09-23 2013-02-19 Janssen Pharmaceutica N.V. Hexahydro-cycloheptapyrazole cannabinoid modulators
US8378096B2 (en) * 2005-09-23 2013-02-19 Janssen Pharmaceutica N.V. Hexahydro-cycloheptapyrazole cannabinoid modulators
EA200800890A1 (ru) * 2005-09-23 2009-02-27 Янссен Фармацевтика Н.В. Модуляторы гексагидроциклогептапиразол каннабиноида
EP1937646A1 (en) 2005-09-23 2008-07-02 Janssen Pharmaceutica N.V. Tetrahydro-cyclopentyl pyrazole cannabinoid modulators
US20070117858A1 (en) * 2005-11-23 2007-05-24 Mingde Xia Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators
EP1979593B1 (en) * 2006-02-03 2017-12-06 Rolls-Royce Corporation Gas turbine engine fuel system with fuel metering valve
WO2007095513A1 (en) * 2006-02-14 2007-08-23 Janssen Pharmaceutica, Nv Tetrahydr0-2h-indaz0le derivatives for use as cannabinoid modulators
WO2007112402A1 (en) * 2006-03-27 2007-10-04 Janssen Pharmaceutica N.V. Tetrahydro-1h-1,2,6-triaza-azulene cannabinoid modulators
US20070254911A1 (en) * 2006-03-27 2007-11-01 Mingde Xia Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators
WO2007122638A2 (en) * 2006-04-26 2007-11-01 Ratnamani Bio-Chemicals & Pharmaceuticals Pvt. Ltd. An improved process for preparation of lamotrigine intermediates
EP2024345B1 (en) * 2006-05-31 2009-12-16 Calaire Chimie SAS Method for preparing lamotrigine and its intermediate 2,3-dichlorobenzoyl chloride
GB0613836D0 (en) * 2006-07-13 2006-08-23 Univ Greenwich New medical use of triazine derivatives
US20120142919A1 (en) 2006-08-02 2012-06-07 Medichem, S.A. Method for synthesizing lamotrigine
WO2008019798A1 (en) * 2006-08-14 2008-02-21 Lonza Ag A process for the preparation of lamotrigine
EP2117538A1 (en) 2007-01-24 2009-11-18 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
US7943653B2 (en) * 2007-08-13 2011-05-17 Janssen Pharmaceutica N.V. Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators
US20090076010A1 (en) * 2007-09-13 2009-03-19 Protia, Llc Deuterium-enriched lamotrigine
US8486927B2 (en) * 2007-11-09 2013-07-16 Thar Pharmaceuticals Crystalline forms of lamotrigine
GB0800741D0 (en) 2008-01-16 2008-02-20 Univ Greenwich Cyclic triazo and diazo sodium channel blockers
US20100190752A1 (en) 2008-09-05 2010-07-29 Gruenenthal Gmbh Pharmaceutical Combination
US8772479B2 (en) 2009-05-13 2014-07-08 Nektar Therapeutics Oligomer-containing substituted aromatic triazine compounds
EP2263657B1 (en) 2009-05-20 2013-07-17 Ranbaxy Laboratories Limited Controlled release lamotrigine formulations
GB2471713A (en) * 2009-07-08 2011-01-12 Univ Greenwich 1,2,4-triazine derivatives and their use as sodium channel blockers
GB2471729A (en) 2009-07-08 2011-01-12 Univ Greenwich 1,2,4-triazine derivatives and their use as sodium channel blockers
US20110052686A1 (en) * 2009-09-03 2011-03-03 Ranbaxy Laboratories Limited Modified release lamotrigine tablets
GB201111712D0 (en) 2011-07-08 2011-08-24 Gosforth Ct Holdings Pty Ltd Pharmaceutical compositions
WO2013183985A1 (en) 2012-06-05 2013-12-12 Erasmus University Medical Center Rotterdam Method of treating cognitive impairment and compounds for use therein
WO2015092819A2 (en) * 2013-12-21 2015-06-25 Nektar Therapeutics (India) Pvt. Ltd. Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5- amine
EP3307273B1 (en) * 2015-06-12 2020-12-09 University of Greenwich Triazine derivatives as interferon-gamma inhibitors
TWI808952B (zh) 2016-12-16 2023-07-21 瑞士商愛杜西亞製藥有限公司 包含t型鈣通道阻斷劑之醫藥組合
TWI826531B (zh) 2018-09-21 2023-12-21 南韓商愛思開生物製藥股份有限公司 具有㗁二唑之化合物及包含該化合物之醫藥組合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB759014A (en) * 1952-02-26 1956-10-10 Wellcome Found Improvements in triazines and their manufacture
AT190941B (de) * 1954-09-22 1957-07-25 Chemie Linz Ag Verfahren zur Herstellung neuer Guanylhydrazone
US2952677A (en) * 1956-10-01 1960-09-13 Ici Ltd Aminoguanadine compounds
BE663481A (uk) * 1964-05-05
GB1204631A (en) * 1967-10-12 1970-09-09 Shell Int Research Pharmacologically active benzylideneamino guanidines and their use
GB1223491A (en) * 1967-10-13 1971-02-24 American Home Prod Guanidines
US3637688A (en) * 1970-01-09 1972-01-25 American Home Prod 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines
EP0086502B1 (en) * 1979-08-16 1987-03-25 The Wellcome Foundation Limited Substituted aromatic triazines

Also Published As

Publication number Publication date
JPS5625169A (en) 1981-03-10
IE801126L (en) 1980-12-01
BG60427B2 (bg) 1995-03-31
YU145680A (en) 1983-02-28
HU182086B (en) 1983-12-28
MX9202962A (es) 1992-07-01
JPS6133163A (ja) 1986-02-17
EP0021121B1 (en) 1983-05-11
CZ384891A3 (en) 1993-10-13
CS234018B2 (en) 1985-03-14
ZW12980A1 (en) 1982-01-06
JPH0144706B2 (uk) 1989-09-29
IT8048848A0 (it) 1980-05-30
IT1147087B (it) 1986-11-19
EP0021121A1 (en) 1981-01-07
NL950007I1 (nl) 1995-06-16
GEP19960470B (en) 1996-08-29
GR68380B (uk) 1981-12-28
IE49823B1 (en) 1985-12-25
ATA289680A (de) 1982-07-15
ES8104993A1 (es) 1981-05-16
NL950007I2 (nl) 1997-02-03
MY8500062A (en) 1985-12-31
DK153787C (da) 1989-01-16
FI801758A (fi) 1980-12-02
ZA803250B (en) 1982-01-27
US4602017A (en) 1986-07-22
NZ193890A (en) 1984-07-06
EP0059987A1 (en) 1982-09-15
JPH0144179B2 (uk) 1989-09-26
DK233880A (da) 1980-12-02
IL60201A (en) 1984-05-31
AU530999B2 (en) 1983-08-04
DD151309A5 (de) 1981-10-14
PL124029B1 (en) 1982-12-31
PL224633A1 (uk) 1981-02-13
IL60201A0 (en) 1980-07-31
EP0059987B1 (en) 1985-08-14
AR227521A1 (es) 1982-11-15
DK153787B (da) 1988-09-05
US4486354A (en) 1984-12-04
AU5890680A (en) 1980-12-04
FI67844B (fi) 1985-02-28
FI67844C (fi) 1985-06-10
ES491998A0 (es) 1981-05-16
CA1112643A (en) 1981-11-17
SU1055331A3 (ru) 1983-11-15
AU566870B2 (en) 1987-11-05
AT370097B (de) 1983-02-25

Similar Documents

Publication Publication Date Title
UA5576A1 (uk) Спосіб отримання похідних 3,5-діаміно-1,2,4-триазіну або їх кислотно-адітивних солей
YU201180A (en) Process for preparingnew 2,4,6-triiodo-isophalic acid derivatives
YU201280A (en) Process for preparing new 2,4,6-triiodo-isophthalic acid derivatives
PT72079B (en) Process for the preparation of 7-acylamino-3-vinylcephalosporanic acid derivatives
YU267680A (en) Process for obtaining 6 beta-hydroxyalkyl-penicillanic acid derivatives
HU177900B (en) Process for preparing 7alpha-methoxy-7beta-malonamido-3-/1,3,4-thiadiazoly-5-yl/-thiomethy/-1-dethia-1-oxa-3-cefem-4-carboxylic acid derivatives
DE3060427D1 (en) 2-substituted 5-phenoxy-phenylphosphonic acid derivatives, process for preparing them and their use as herbicides
EG12409A (en) Process for preparing of 1-3,3,3-triarylpropyl-4-phenyl-4-piperidinemethanols compounds used as anti diarrheal
HU175053B (hu) Sposob poluchenija proizvodnykh 3,5-di-skobka-terc-butil-skobka zakryta-4-gidroksi-fenil-skobka-alkil-skobka zakryta-karbonyl-amino-alkil-fenoksi-alkil-karbonovykh kislot
ZA804178B (en) Process for the preparation of 2,6-dialkylcyclohexylamines
PT65890B (en) Process for preparing 1,4-diphenyl-3-pyrazoline-5-ones herbicides
PT72176A (en) Process for preparing 2,3-indoledione derivatives
DE3062603D1 (en) 3,5-diamino-1,2,4-triazine derivatives, process for preparing such compounds and pharmaceutical compositions containing them
IL59760A (en) Method for the preparation of 7-oxo-4-thia-1-aza-bicyclo(3,2,0)-heptane-2-carboxylic acid derivatives
PL226254A1 (en) Process for manufacturing novel derivatives of 1,1,2-triphenyl-propane or propene
FR2299329A1 (fr) Procede de preparation de 1,2-benzisothiazoles
PT65685A (en) A process for the preparation of 2,9-dioxatricyclo(4,3,1,03,7)decanes as well as intermediate products thereof
YU45480A (en) Process for producing 2,2-dimethyl-1,2-dimethyl-1,2-dihydroquinoline derivatives used as antioxidats
YU41933B (en) Process for obtaining 6,6-methylene-bis (2,2,4-trimethyl)-1,2-dihydroquinoline derivatives
IL60268A0 (en) Process for the preparation of 3,3-dimethyl-cyclopropane-1,1,2-tricarboxylic acid derivatives,and -halogeno-nitriles as new intermediate products for this process and their preparation
PT71841B (en) Process for preparing of 2,5-diketogluconic acid
PT65256A (en) Process for the preparation of 1-acyl-1,2,3,4-tetrahydro-6-quinolinols
EP0025659A3 (en) Processes for the production of 1,2,3-trihydroxyphenyl compounds; processes for the production of substituted phenol compounds and of derivatives thereof; 2,6-dimethyl phenol derivatives
HU178105B (en) Process for preparing 7beta-/halo-aryl /-malonamido/- 7alpha-methoxy-3-/ alkyl-tetrazol-5-yl- or -1,3,4-thiadiazol-2-yl /-thiomethyl/- 1-dethia-1-oxa-3-cephem-4-carboxylic acid derivatives
FR2335524A1 (fr) Procede de preparation de derives de l'androstene-4 dione-3,17